Acute Treatments with Fasudil or PD98059 Inhibit ROCK and ERK1/2 Signaling Respectively and Attenute Diabetes-induced Vascular Dysfunction in the Mesenteric Vascular Bed. The gene discussed is MAPK3; the disease is diabetes mellitus.